top of page
NEWS
News & updates
Search
Visit to Batavia’s new GMP facility, the Horizon building in Leiden (NL).
On 30th January 2025, LARISSA II consortium partners visited Batavia Biosciences , the consortium partner responsible for producing...
CEPI expands partnership with WBVR to advance Rift Valley Fever vaccine
· CEPI to invest up to $25.9 million, with support from the EU, in trials in East Africa to assess a vaccine candidate against Rift...
Novel Rift Valley fever vaccine dosed in Phase I human trial
LARISSA consortium reaches milestone Novel Rift Valley fever vaccine dosed in Phase I human trial The first healthy volunteer was dosed...
bottom of page